• CAFC Remands Medinol Patent Suit Against Cordis After SCOTUS Overturns Laches Finding

    On Thursday, April 20th, the Court of Appeals for the Federal Circuit issued a decision in Medinol Ltd. v. Cordis Corporation et. al. which vacated and remanded a lower court’s ruling that claims of patent infringement alleged by Israeli pharmaceutical firm Medinol were barred by the equitable defense of laches. The Federal Circuit’s decision comes after the U.S. Supreme Court overturned the Federal Circuit’s previous precedence on laches as an equitable defense in SCA Hygiene Products v. First…

    Continue Reading ...
  • Polsinelli Adds Leading Technology Lawyer William Tanenbaum in New York

    Polsinelli announced the addition of prominent technology and intellectual property attorney William A. Tanenbaum to its New York office.  Tanenbaum joins the firm’s Technology Transactions & Data Privacy group and will serve as Co-Chair of the Healthcare Technology & Innovation Group.  His practice focuses on transactions, litigation, and strategic counseling in the intellectual property, technology, cybersecurity, health care IT and IP, financial services IT and IP, outsourcing and…

    Continue Reading ...
  • Polsinelli Adds Leading Technology Lawyer William Tanenbaum in New York

    Polsinelli announced the addition of prominent technology and intellectual property attorney William A. Tanenbaum to its New York office.  Tanenbaum joins the firm’s Technology Transactions & Data Privacy group and will serve as Co-Chair of the Healthcare Technology & Innovation Group.  His practice focuses on transactions, litigation, and strategic counseling in the intellectual property, technology, cybersecurity, health care IT and IP, financial services IT and IP, outsourcing and…

    Continue Reading ...
  • Webinar on Patents for Combination Therapies

    J A Kemp will be offering a webinar entitled “Patenting Antibodies at the EPO” on May 17, 2018 starting at 15:30 (Greenwich Mean Time). Sarah Roques and Pamela Tuxwirth of J A Kemp will address the following topics: • When broad antibody claims can be obtained • How to approach inventive step when the target is known • What data to provide to support inventive step • Functional/epitope claims • Other routes to patentability Those wishing to register can do so here.

    Continue Reading ...
  • PLI Program on USPTO Post-Grant Patent Trials

    Practising Law Institute (PLI) will be holding a program entitled “USPTO Post-Grant Patent Trials 2018: Change & Recalibration” in San Francisco (May 15) and New York (September 21). Webcasts of both sessions will be offered, and groupcasts will be held in Philadelphia, Indianapolis, New Brunswick, NJ, Pittsburgh, and Mechanicsburg, PA on September 21. The San Francisco session of the program will offer presentations on the following topics: • Roadblock PTAB: Hardening Patent Portfolios and Adjusting Patent Prosecution Strategies • PTAB Launch: The Preliminary Proceeding – New Tactics, Evolving Estoppel Risks and Trial Institution • PTAB Trial Route: The Article I…

    Continue Reading ...
  • Webinar on U.S. Patent Exclusivity for Biologics

    Strafford will be offering a webinar entitled “Patent Exclusivity Health Checks for Biologics: Are Your U.S. Patents Ready to Maximize ROI?” on May 17, 2018 from 1:00 to 2:30 pm (EDT). M. Paul Barker, Steven P. O’Connor, and Sanya Sukduang of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel on the essentials of patent exclusivity that are in critical need of independent checking, and discuss crucial health checks on U.S. patent exclusivity for biologics in Phase II efficacy trials and proceedings through large scale randomized Phase III clinical trials, submission of the BLA, and subsequent approval and marketing….

    Continue Reading ...
  • 傷(つける)

                            目次はこちら

    傷(つける)

    $$ Lateral movement of the piston rod 706 displaces the seal arrangement 714 in its recess 716 but does not impair the seal provided. / …

    Continue Reading ...